A new sensitive flow-injection chemiluminescence method for the determination of H(2)-receptor antagonists.

Based on the chemiluminescence (CL) intensity generated from the potassium ferricyanide [K(3)Fe(CN)(6)]-rhodamine 6G system in sodium hydroxide (NaOH) medium, a new sensitive flow-injection chemiluminescence (FI-CL) method has been developed, validated and applied for the determination of three kinds of H(2)-receptor antagonists: cimetidine (CIMT), ranitidine (RANT) hydrochloride and famotidine (FAMT). Under the optimum conditions, the linear range for the determination was 1.0 x 10(-9)-7.0 x 10(-5) g/ml for CIMT, 1.0 x 10(-9)-5.0 x 10(-5) g/mL for RANT hydrochloride and 5.0 x 10(-9)-7.0 x 10(-5) g/mL for FAMT. During 11 repeated measurements of 1.0 x 10(-6) g/mL sample solutions, the relative standard deviations (RSDs) were all <5%. The detection limit was 8.56 x 10(-10) g/mL for CIMT, 8.69 x 10(-10) g/mL for RANT hydrochloride and 2.35 x 10(-9) g/mL for FAMT (S:N = 3). This method has been successfully implemented for the analysis of H(2)-receptor antagonists in pharmaceuticals.

[1]  A. Zarghi,et al.  Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column. , 2005, Journal of pharmaceutical and biomedical analysis.

[2]  Witold Ciesielski,et al.  Square wave adsorptive stripping voltammetric determination of famotidine in urine. , 2005, Talanta.

[3]  K. Basavaiah,et al.  Determination of ranitidine hydrochloride in pharmaceutical preparations by titrimetry and visible spectrophotometry using bromate and acid dyes. , 2004, Farmaco.

[4]  Ulrich J. Griesser,et al.  Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy , 2003 .

[5]  J. Taguchi,et al.  Voltammetric determination of weak bases based on oxidation of α-tocopherol in an unbuffered solution , 2003 .

[6]  T. Stafilov,et al.  Development of an HPLC method for the determination of ranitidine and cimetidine in human plasma following SPE. , 2003, Journal of pharmaceutical and biomedical analysis.

[7]  V. Tomás,et al.  Direct determination of ranitidine and famotidine by CE in serum, urine and pharmaceutical formulations. , 2002, Journal of pharmaceutical and biomedical analysis.

[8]  A. Shalaby,et al.  Potentiometric determination of famotidine in pharmaceutical formulations. , 2002, Journal of pharmaceutical and biomedical analysis.

[9]  M. Shamsipur,et al.  Preparation of a cimetidine ion-selective electrode and its application to pharmaceutical analysis. , 2002, Journal of pharmaceutical and biomedical analysis.

[10]  Z. Değim,et al.  pH-Metric log K calculations of famotidine, naproxen, nizatidine, ranitidine and salicylic acid. , 2001, Farmaco.

[11]  T. Rades,et al.  Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD. , 2001, Journal of pharmaceutical and biomedical analysis.

[12]  J. Pawliszyn,et al.  Automated in-tube solid-phase microextraction-liquid chromatography-electrospray ionization mass spectrometry for the determination of ranitidine. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[13]  J. Novaković.  High-performance thin-layer chromatography for the determination of ranitidine hydrochloride and famotidine in pharmaceuticals , 1999 .

[14]  B. Hindson,et al.  Determination of Ranitidine and Salbutamol by Flow Injection Analysis with Chemiluminescence Detection , 1999 .

[15]  M. A. Kelly,et al.  Optimisation, validation and application of a capillary electrophoresis method for the determination of ranitidine hydrochloride and related substances. , 1998, Journal of chromatography. A.

[16]  E. Hassan,et al.  Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations. , 2002, Journal of pharmaceutical and biomedical analysis.

[17]  J. Pawliszyn,et al.  ランチジン定量用の自動化インチューブ固相ミクロ抽出‐液体クロマトグラフィー‐エレクトロスプレイイオン化質量分析 , 1999 .